Corton Capital Inc. Immatics N.V. Transaction History

Corton Capital Inc.

$183 Million
Q2 2024

A detailed history of Corton Capital Inc. transactions in Immatics N.V. stock. As of the latest transaction made, Corton Capital Inc. holds 21,339 shares of IMTX stock, worth $250,306. This represents 0.14% of its overall portfolio holdings.

Number of Shares

21,339

Holding current value

$250,306

% of portfolio

0.14%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$9.78 - $13.49 $208,695 - $287,863	21,339 New	21,339 $247,000
Q2 2022 Aug 15, 2022	BUY	$6.0 - $9.37 $219,714 - $343,120	36,619 New	36,619 $319,000

Others Institutions Holding IMTX

# of Institutions

Shares Held

76.6M

Call Options Held

571K

Put Options Held

210K

Rtw Investments, LP New York, NY

10M
Shares

$117 Million
1.94% of portfolio
Wellington Management Group LLP Boston, MA

9.54M
Shares

$112 Million
0.02% of portfolio
Perceptive Advisors LLC New York, NY

8.09M
Shares

$94.9 Million
2.72% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

7.43M
Shares

$87.2 Million
0.05% of portfolio
Baker Bros. Advisors LP New York, NY

6.44M
Shares

$75.6 Million
1.0% of portfolio

View Full List

About Immatics N.V.

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $894M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

More about IMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.

Account